Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients (Certi-CMV)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2012 by Medical University of Vienna.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Marcus Saemann, Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT00828503
First received: January 23, 2009
Last updated: August 30, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)